| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/10/2008 | WO2008004610A1 Method of treating genetic disease caused by nonsense mutation |
| 01/10/2008 | WO2008004598A1 Erythropoietin-producing organoid precursor, method of constructing the same and method of treating erythropoietin-related disease |
| 01/10/2008 | WO2008004473A1 Novel protein complex, method for maturation of cobalt-type low-molecular-weight nitrile hydratase using the protein complex, matured cobalt-type low-molecular-weight nitrile hydratase, and method using the nitrile hydratase |
| 01/10/2008 | WO2008004406A1 Agent for modulating mast cell degranulation |
| 01/10/2008 | WO2008003925A2 Complement protein |
| 01/10/2008 | WO2008003870A2 Promoter expressed in the dehiscence zone of dry fruits |
| 01/10/2008 | WO2008003783A2 Resistance to powdery mildew and absence of necrosis in cucumis sativus |
| 01/10/2008 | WO2008003776A2 Method for insulating in parallel double and single-stranded nucleic acids and for selectively removing double-stranded nucleic acids from a mixture of double and single-stranded nucleic acids |
| 01/10/2008 | WO2008003763A1 Csf3r polypeptides and uses thereof |
| 01/10/2008 | WO2008003666A1 Transplastomic plants expressing lumen-targeted protein |
| 01/10/2008 | WO2008003656A2 Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics |
| 01/10/2008 | WO2008003473A2 Compositions and methods for enhancing the efficacy of il-2 mediated immune responses |
| 01/10/2008 | WO2008003356A1 Resistance to powdery mildew and absence of necrosis in cucumis sativus |
| 01/10/2008 | WO2008003116A2 Method for engineering immunoglobulins |
| 01/10/2008 | WO2008003115A1 Method for engineering t-cell receptors |
| 01/10/2008 | WO2008003103A2 Novel multivalent immunoglobulins |
| 01/10/2008 | WO2007131654A3 Anti-inflammatory fusion protein |
| 01/10/2008 | WO2007128477A9 SHORT INTERFERING RIBONUCLEIC ACID (siRNA) FOR ORAL ADMINISTRATION |
| 01/10/2008 | WO2007128477A2 SHORT INTERFERING RIBONUCLEIC ACID (siRNA) FOR ORAL ADMINISTRATION |
| 01/10/2008 | WO2007127381A3 Delta-8 desaturase and its use in making polyunsaturated fatty acids |
| 01/10/2008 | WO2007121946A3 Means for inhibiting the expression of cd31 |
| 01/10/2008 | WO2007118849A3 Methods and means for assessing hiv gag/protease inhibitor therapy |
| 01/10/2008 | WO2007115385A3 Transfer plasmidic vector and recombinant canarypox virus |
| 01/10/2008 | WO2007110314A3 Proteins associated with abiotic stress response and homologs |
| 01/10/2008 | WO2007107516A3 D-amino acid selection for soybean |
| 01/10/2008 | WO2007107380A3 Use of pol iii promoters for controlled expression of therapeutic proteins |
| 01/10/2008 | WO2007104738A3 Acylated single chain insulin |
| 01/10/2008 | WO2007091178A3 Construction of new variants of dextransucrase dsr-s by genetic engineering |
| 01/10/2008 | WO2007089611A3 Compositions and their uses directed to huntingtin |
| 01/10/2008 | WO2007089334A3 Assay for parkinson's disease therapeutics and enzymatically active parkin preparations useful therein |
| 01/10/2008 | WO2007074496A3 Vector for efficient selection and/or maturation of an antibody and uses thereof |
| 01/10/2008 | WO2007038241A3 Modulation of mesenchymal and metastatic cell growth |
| 01/10/2008 | WO2007027947A3 Method of using pore-forming peptides for genetic transformation, protein extraction, and transmembrane transport |
| 01/10/2008 | WO2007022478A3 Transcription factors in neuronal dendrites-dendritic protein synthesis and cell death |
| 01/10/2008 | WO2006110688A3 Rnai therapeutic for respiratory virus infection |
| 01/10/2008 | WO2006110680A8 Rapid generation of long synthetic centromeric tandem repeats for mammalian artificial chromosome formation |
| 01/10/2008 | WO2006099152A3 Slow-maturing, determinate peas |
| 01/10/2008 | WO2006091766A3 Human trophoblast stem cells and use thereof |
| 01/10/2008 | WO2006090750A8 ANTI-IgSF4 ANTIBODY AND UTILIZATION OF THE SAME |
| 01/10/2008 | WO2006070752A9 Control program and culture apparatus |
| 01/10/2008 | WO2006036779A3 Site-specific labeling of proteins for nmr studies |
| 01/10/2008 | WO2005061534A3 Improved tuberculosis vaccines |
| 01/10/2008 | WO2005033699A3 Materials and methods relating to breast cancer classification |
| 01/10/2008 | WO2003078577A8 Cloning of cytochrome p450 genes from nicotiana |
| 01/10/2008 | US20080010703 Yield and stress tolerance in transgenic plants |
| 01/10/2008 | US20080010702 Plants having improved tolerance to various types of environmental stress, their production, and polyamine metabolism-related enzyme gene |
| 01/10/2008 | US20080010701 polynucleotides encoding polypeptides active in fructan, cellulose, starch and/or tannin biosynthetic pathways; transgenic plant cells |
| 01/10/2008 | US20080010700 Removal of tyrosine, glycosylation sites and epitopes which bind to anti-patatin antibodies; insecticidal and acyl lipid hydrolase activity, reduced allergenicity |
| 01/10/2008 | US20080010698 Expansin Polypeptides |
| 01/10/2008 | US20080010697 Methods of Expressing Heterologous Protein in Plant Seeds Using Monocot Non Seed-Storage Protein Promoters |
| 01/10/2008 | US20080010696 Method of Determining Gene Relating to Favorable Beef Taste and Texture |
| 01/10/2008 | US20080010694 Method of acquiring immunological tolerance |
| 01/10/2008 | US20080010693 Human coagulation factor VII polypeptides |
| 01/10/2008 | US20080010026 Gene sequence of L-rhamnose isomerase having new catalytic function and use thereof |
| 01/10/2008 | US20080009614 Method for extracting nucleic acids |
| 01/10/2008 | US20080009609 Cloning and sequencing of pyruvate decarboxylase (PDC) genes from bacteria and uses therefor |
| 01/10/2008 | US20080009608 Sitosterolemia susceptibility gene (SSG): compositions and methods of use |
| 01/10/2008 | US20080009459 Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences |
| 01/10/2008 | US20080009457 Reaction of Rna and cochleate |
| 01/10/2008 | US20080009456 modified oligonucleotide for gene therapy; as antitumor agent, anticarcinogenic agent; Inhibiting synthesis and function; arresting cellular proliferation |
| 01/10/2008 | US20080009455 Immunostimulatory oligonucleotides |
| 01/10/2008 | US20080009454 Polynucleotide |
| 01/10/2008 | US20080009447 Modulating cytokine or hormone signalling in an animal comprising up-regulating the expression of SOCS sequence in the animal |
| 01/10/2008 | US20080009446 Recombinant human albumin fusion proteins with long-lasting biological effects |
| 01/10/2008 | US20080009444 Biologically active complex of NR6 and cardiotrophin-like-cytokine |
| 01/10/2008 | US20080009439 Compositions and Methods of Use for a Fibroblast Growth Factor |
| 01/10/2008 | US20080009066 Plant gene encoding trehalose metabolism enzymes |
| 01/10/2008 | US20080009065 Genes encoding insect odorant receptors and uses thereof |
| 01/10/2008 | US20080009060 Methods of discovering chemicals capable of functioning as gene expression modulators |
| 01/10/2008 | US20080009056 Polypeptide, cDNA encoding the same and use of them |
| 01/10/2008 | US20080009053 Modified Ethylenediamine-N, N'-Disuccinate: Ethylnediamine Lyase |
| 01/10/2008 | US20080009052 a polypeptide having a higher catalytic activity for oxidation of cephalosporin C to glutaryl-7-aminocephalosporanic acid, than that of the wild-type polypeptide |
| 01/10/2008 | US20080009047 Non-Recombinant Saccharomyces Strains That Grow On Xylose |
| 01/10/2008 | US20080009042 separating the yeast from the culture medium to yield an albumin solution; subjecting the albumin solution to positive mode cation exchange, affinity, and positive mode anion exchange chromatography; and concentrating and formulating the albumin with sodium octanoate and sodium chloride |
| 01/10/2008 | US20080009039 Recombinant Microorganism |
| 01/10/2008 | US20080009037 Protein glycosylation modification in methylotrophic yeast |
| 01/10/2008 | US20080009036 DNA which encodes a protein that is capable of binding to 5'GGTACC-3'; producing recombinant Acc65I restriction endonuclease by culturing a host cell transformed with a vector containing the DNA |
| 01/10/2008 | US20080009033 Nucleic acid sequences encoding secretion-associated proteins; cells genetically manipulated to have an altered capacity to produce expressed proteins |
| 01/10/2008 | US20080009032 Method for Producing Yellow Flower by Controlling Flavonoid Synthetic Pathway |
| 01/10/2008 | US20080009025 Protein kinase regulation |
| 01/10/2008 | US20080009021 Identifying modulators of ubiquitin-mediated proteolysis; treatment and prevention of cell proliferative, arthritic and respiratory system disorders |
| 01/10/2008 | US20080009016 Novel Monkey Gpr103 and Monkey Qrfp and Method of Evaluating Compound By Using Gpr103 |
| 01/10/2008 | US20080009014 Receptor activator of NF-kappaB |
| 01/10/2008 | US20080009009 Device and method for high-throughput quantification of mRNA from whole blood |
| 01/10/2008 | US20080009008 Composition and method for treating lupus nephritis |
| 01/10/2008 | US20080009006 Expression cloning in filamentous fungi |
| 01/10/2008 | US20080009004 Claudin polypeptides, polynucleotides, and methods of making and use thereof |
| 01/10/2008 | US20080008717 Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus |
| 01/10/2008 | US20080008715 antibodies which recognizes membrane glycoprotein (ULBP) for use in treatment and prevention of cell proliferative disorders; immunotherapy |
| 01/10/2008 | US20080008713 Tumor Necrosis Factor Receptor I (TNFR1); immunoglobulins; competitive binding; inhibiting signal transduction; pharmacokinetics; storage stability |
| 01/10/2008 | US20080008706 B7S1: an immune modulator |
| 01/10/2008 | US20080008703 Humanized Antibody Specific For Tumor Necrosis Factor-Alpha |
| 01/10/2008 | US20080008700 Multimeric Fc Receptor Polypeptides |
| 01/10/2008 | US20080008697 Polynucleotides encoding novel PCSK9 variants |
| 01/10/2008 | US20080008691 Modified growth hormone |
| 01/10/2008 | US20080008690 AAV virions with decreased immunoreactivity and uses therefor |
| 01/10/2008 | US20080008687 Transposon-Based Targeting System |
| 01/10/2008 | US20080008685 Viral vectors |
| 01/10/2008 | US20080008684 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 01/10/2008 | US20080008683 Polypeptide Sequence Involved in the Modulation of the Immunosuppresive Effect of Viral Proteins |